NCT03979105View on ClinicalTrials.gov

Cardiovascular Safety After Continuous Ketamine Infusion

CompletedOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

July 1, 2017

Primary Completion Date

November 1, 2018

Study Completion Date

December 31, 2018

Conditions

PainKetamine Adverse ReactionPostoperative Pain

Interventions

DRUG

Ketamine

Drug: Ketamine Side effects associated with ketamine infusion to treat acute pain, were reviewed after 48 hours of exposure and frequency of tachycardia, hypertension, hallucinations, delirium and nightmares were registrated for comparison

Trial Locations (2)

Unknown

hospital universitario San Vicente Fundacion, Medellín

050010

Adriana Cadavid, MD, Medellín

All Listed Sponsors

lead

Universidad de Antioquia

OTHER

NCT03979105 - Cardiovascular Safety After Continuous Ketamine Infusion | Biotech Hunter | Biotech Hunter